|1.46||-0.01 / -0.68%|
Data as of 4:02pm ET
|1.49||+0.03 / +2.05%|
The 3 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 6.00, with a high estimate of 7.50 and a low estimate of 4.00. The median estimate represents a +310.96% increase from the last price of 1.46.
The current consensus among 3 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.